OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation against prostate-specific antigen (PSA) screening in men aged 75 and older on frequency of PSA screening in elderly men. DESIGN: Retrospective, cross-sectional analysis. SETTING: Fifteen community primary care practices in western Massachusetts. PARTICIPANTS: Men aged 65 and older with one or more annual physicals between January 1, 2006, and December 31, 2010. MEASUREMENTS: PSA testing was determined from the electronic health record. Mixed-effects logistic regression was used to model the rate of PSA testing over time for two age groups: 65 to 74, and 75 and older. RESULTS: Of the 7,833 men in this study, 60% were younger than 75. PSA ...
ImportanceDespite guidelines recommending against prostate-specific antigen (PSA) screening in elder...
Purpose: Prostate cancer screening is a controversial topic. We examined trends in Prostate Specific...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-base...
Background/Aims: Controversial clinical guidelines have recommended against widespread prostate-spec...
PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-base...
treatments, and annual direct payments in older men cared for by primary care providers with high or...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate c...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
Purpose:To assess changes of prostate-specific antigen (PSA) testing following recent US Preventive ...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: In 2008, the United States Preventive Services Task Force recommended against prostate s...
Background: Controversy surrounds prostate-specific antigen (PSA) testing for prostate cancer screen...
ImportanceDespite guidelines recommending against prostate-specific antigen (PSA) screening in elder...
Purpose: Prostate cancer screening is a controversial topic. We examined trends in Prostate Specific...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-base...
Background/Aims: Controversial clinical guidelines have recommended against widespread prostate-spec...
PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-base...
treatments, and annual direct payments in older men cared for by primary care providers with high or...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate c...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
Purpose:To assess changes of prostate-specific antigen (PSA) testing following recent US Preventive ...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: In 2008, the United States Preventive Services Task Force recommended against prostate s...
Background: Controversy surrounds prostate-specific antigen (PSA) testing for prostate cancer screen...
ImportanceDespite guidelines recommending against prostate-specific antigen (PSA) screening in elder...
Purpose: Prostate cancer screening is a controversial topic. We examined trends in Prostate Specific...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...